| 4D flow evaluation of blood non-Newtonian behavior in left ventricle flow analysis A Riva, F Sturla, A Caimi, S Pica, D Giese, P Milani, G Palladini, ... Journal of Biomechanics 119, 110308, 2021 | 7 | 2021 |
| 523 4D flow CMR for diastolic function assessment in cardiac amyloidosis S Pica, F Piatti, P Milani, R Mussinelli, A Foli, M Basset, A Camporeale, ... European Heart Journal-Cardiovascular Imaging 20 (Supplement_2), jez124. 008, 2019 | 1 | 2019 |
| 591 SEQUENCE OF DIAGNOSTIC TESTING IN CARDIAC AMYLOIDOSIS: EARLY MONOCLONAL PROTEIN STUDY IS ASSOCIATED WITH BETTER OUTCOMES IN AL AMYLOIDOSIS P Milani, F Fabris, R Mussinelli, L Obici, M Nanci, M Basset, P Benvenuti, ... European Heart Journal Supplements 24 (Supplement_K), suac121. 471, 2022 | | 2022 |
| 593 PRESENTATION AND OUTCOME OF PATIENTS WITH COEXISTING CARDIAC AL AND ATTR AMYLOIDOSIS B Marco, S Schönland, B Tamara, L Verga, P Milani, A Foli, M Nanci, ... European Heart Journal Supplements 24 (Supplement_K), suac121. 428, 2022 | | 2022 |
| 632 PREVALENCE OF VARIANT GENOTYPE IN PATIENTS WITH SUSPECTED CARDIAC ATTR AMYLOIDOSIS R Mussinelli, P Milani, S Casarini, M Nuvolone, F Fabris, S Perlini, ... European Heart Journal Supplements 24 (Supplement_K), suac121. 655, 2022 | | 2022 |
| A European Collaborative Study of 230 Patients to Assess the Role of Cyclophosphamide, Bortezomib and Dexamethasone in Upfront Treatment of Patients with Systemic AL Amyloidosis G Palladini, S Sachchithanantham, P Milani, JD Gillmore, A Foli, ... Blood 124 (21), 305, 2014 | | 2014 |
| A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis G Palladini, S Sachchithanantham, P Milani, J Gillmore, A Foli, ... Blood, The Journal of the American Society of Hematology 126 (5), 612-615, 2015 | 423 | 2015 |
| A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis AD Wechalekar, SO Schonland, E Kastritis, JD Gillmore, MA Dimopoulos, ... Blood, The Journal of the American Society of Hematology 121 (17), 3420-3427, 2013 | 506 | 2013 |
| A nationwide prospective registry of bortezomib-based therapy in light chain (AL) amyloidosis G Palladini, S Celant, P Milani, V Summa, G Affronti, PP Olimpieri, ... Leukemia & Lymphoma 63 (1), 205-211, 2022 | 8 | 2022 |
| A patient with AL amyloidosis with negative free light chain results P Milani, V Valentini, G Ferraro, M Basset, F Russo, A Foli, G Palladini, ... Clinical Chemistry and Laboratory Medicine (CCLM) 54 (6), 1035-1037, 2016 | 10 | 2016 |
| A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis G Palladini, P Milani, A Foli, M Basset, F Russo, S Perlini, G Merlini Blood, The Journal of the American Society of Hematology 129 (15), 2120-2123, 2017 | 105 | 2017 |
| A phase II trial of cyclophosphamide, lenalidomide and dexamethasone in previously treated patients with AL amyloidosis G Palladini, P Russo, P Milani, A Foli, F Lavatelli, M Nuvolone, S Perlini, ... Haematologica 98 (3), 433, 2013 | 80 | 2013 |
| A powerful oral triplet for AL amyloidosis. G Palladini, P Milani, G Merlini British Journal of Haematology 189 (4), 2020 | 2 | 2020 |
| A practical approach to the diagnosis of systemic amyloidoses C Fernández de Larrea, L Verga, P Morbini, C Klersy, F Lavatelli, A Foli, ... Blood, The Journal of the American Society of Hematology 125 (14), 2239-2244, 2015 | 211 | 2015 |
| A randomized phase III trial of melphalan and dexamethasone (MDex) versus bortezomib, melphalan and dexamethasone (BMDex) for untreated patients with AL amyloidosis E Kastritis, X Leleu, B Arnulf, E Zamagni, MT Cibeira, F Kwok, P Mollee, ... Blood 128 (22), 646, 2016 | 64 | 2016 |
| A randomized phase III trial of melphalan and dexamethasone (MDex) versus bortezomib, melphalan and dexamethasone (BMDex) for untreated patients with AL amyloidosis E Kastritis, X Leleu, B Arnulf, E Zamagni, MT Cibeira, F Kwok, P Mollee, ... Clinical Lymphoma, Myeloma and Leukemia 15, e59-e60, 2015 | 8 | 2015 |
| A randomized phase III trial of melphalan and dexamethasone (MDex) versus bortezomib, melphalan and dexamethasone (BMDex) for untreated patients with AL amyloidosis E Kastritis, X Leleu, B Arnulf, E Zamagni, P Mollee, MT Cibeira, ... Blood, The Journal of the American Society of Hematology 124 (21), 35-35, 2014 | 15 | 2014 |
| A simple model to predict survival using age, comorbidities and functional status in patients with multiple myeloma (MM) P Milani, F Buadi, M Gertz, G Merlini, M Lacy, G Palladini, J Lust, D Dingli, ... Clinical Lymphoma, Myeloma and Leukemia 15, e94-e95, 2015 | 1 | 2015 |
| A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis G Palladini, U Hegenbart, P Milani, C Kimmich, A Foli, AD Ho, MV Rosin, ... Blood, The Journal of the American Society of Hematology 124 (15), 2325-2332, 2014 | 471 | 2014 |
| A strategy for the selection of RT-qPCR reference genes based on publicly available transcriptomic datasets A Nevone, F Lattarulo, M Russo, G Panno, P Milani, M Basset, ... Biomedicines 11 (4), 1079, 2023 | 4 | 2023 |
